Business
BD Aims to Save Lives by Empowering Women with Choice and Access to Cervical Cancer Screening Self-Collected At Home
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has submitted an application to the U.S. Food and Drug Administration for a new, at-home human papillomavirus (HPV) test that enables patients to self-collect a sample in the comfort of their own home using a swab the size of a Q-tip that simplifies processing at the lab and reports more high-risk strains of HPV than any other test on the market today.
About this update from Becton, Dickinson And Company
[{"type":"text","content":"New FDA Submission Includes Self-Collection Swab and High-Tech Laboratory Robotics that Report More High-Risk HPV Strains Than Any Other Test","length":141,"tagName":"p","attribs":{}},{"type":"text","content":"FRANKLIN LAKES, N.J., July 31, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has submitted an application to the U.S. Food and Drug Administration for a new, at-home human papillomavirus (HPV) test that enables patients to self-collect a sample in the comfort of their own home using a swab the size of a Q-tip that simplifies processing at the lab and reports more high-risk strains of HPV than any other test on the market today.","length":518,"tagName":"p"},{"type":"image","alt":"BD announced it has submitted an application to the U.S. FDA for a new, at-home HPV test that enables patients to self-collect a sample in the comfort of their own home using a swab the size of a Q-tip that simplifies processing at the lab and reports more high-risk strains of HPV than any other test on the market today.","displaySize":"","headline":null,"caption":"BD announced it has submitted an application to the U.S. FDA for a new, at-home HPV test that enables patients to self-collect a sample in the comfort of their own home using a swab the size of a Q-tip that simplifies processing at the lab and reports more high-risk strains of HPV than any other test on the market today.","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":220,"url":"https://media.zenfs.com/en/prnewswire.com/eef30aecd49e08227bff663b5fbe7bd6"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/1zVvrKmAWHxxxwlZKTMvXQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTM4ODtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/eef30aecd49e08227bff663b5fbe7bd6","width":400,"height":220}},"href":"https://mma.prnewswire.com/media/2742137/FDA_Application_At_Home_HPV_Test.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":""We envision a world where women are empowered with access and a choice for their HPV screening, whether it be in a routine visit at the doctor's office or the comfort and privacy of their own home via a self-collected sample," said Nikos Pavlidis, president of BD Diagnostic Solutions. "Cervical cancer and the loss of ...